Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Former Pfizer Scientist-Led Startup Zai Lab Taps Banks for $150M IPO August 10, 2017 Optinose Gets $100M Debt Financing From Athyrium Capital Management January 1, 2018 Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test June 5, 2017
